Business Context and Reporting Period
This Form 8-K Current Report was filed by Skye Bioscience, Inc. on September 6, 2023, with the earliest event reported on the same date. The filing primarily addresses a material modification to the rights of security holders through a reverse stock split.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company implemented a 1-for-250 reverse stock split effective September 8, 2023.
- Share Count Reduction: Authorized shares were reduced from 5,000,000,000 to 20,000,000. Issued and outstanding shares were reduced from approximately 3,078,137,871 to approximately 12,312,551.
- Ownership Impact: Stockholder percentage ownership and proportional voting power remain virtually unchanged, subject only to minor rounding adjustments for fractional shares.
- Trading Details: The CUSIP number changed to 83086J200. The ticker symbol "SKYE" remains unchanged, but a "D" suffix will be temporarily appended for 20 trading days following the effective date.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard disclosure that the press release information is not deemed "filed" under Section 18 of the Exchange Act. The reverse split was approved by the Board of Directors under Nevada Revised Statutes Section 78.207, meaning no stockholder approval was required.
Investor Verification Checklist
- Verify the effective date of the reverse split (September 8, 2023) and the 20-day trading suspension/suffix period.
- Confirm the new CUSIP number (83086J200) for trading and settlement purposes.
- Review the handling of fractional shares to understand potential cash-in-lieu payments or rounding adjustments.
- Check subsequent filings for the removal of the "D" suffix from the ticker symbol after the 20-day period.